Menu
1 min read · estimated
APPROVED USE
What FDA approved
An approximately 90-minute infusion option for patients with follicular lymphoma who had three standard-rate doses without an infusion reaction of grade 3 or higher.
LAMPGEN ANALYSIS
Why it matters
This schedule change can reduce chair time for patients who tolerated the first three administrations.
What research teams should watch
Check prior infusion-reaction grades before changing the rate and document the shortened schedule.
PRIMARY RECORDS